Buckingham Strategic Wealth’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Buckingham Strategic Wealth's AMGN Position: Q2 2024 in Review
Buckingham Strategic Wealth reduced its Amgen (AMGN) stake by 1.9% in Q2 2024, selling an estimated $73.7K and leaving 12,765 shares worth $3.99M. The position accounts for 0.04% of the portfolio, ranked #169.
Buckingham Strategic Wealth first reported a position in AMGN in Q2 2013 and has held it in 45 quarters since. The position peaked at $5.05M in Q3 2023. 2,784 funds tracked by Wall St. Rank hold AMGN as of Q2 2024.
- Buckingham Strategic Wealth held 12,765 shares of Amgen worth $3.99M as of Q2 2024.
- Buckingham Strategic Wealth sold 251 Amgen shares in Q2 2024, an estimated $73.7K.
- Amgen made up 0.04% of Buckingham Strategic Wealth's portfolio in Q2 2024, its #169 holding.
- Buckingham Strategic Wealth first reported a position in Amgen in Q2 2013 and has held it in 45 quarters since.
- Buckingham Strategic Wealth's Amgen position peaked at $5.05M in Q3 2023.
- 2,784 funds tracked by Wall St. Rank held Amgen as of Q2 2024.
Based on Buckingham Strategic Wealth's 13F filing for Q2 2024, filed 12 Aug 2024.